Diabetic kidney disease: from epidemiology to clinical perspectives.
about
Adenosine monophosphate-activated protein kinase in diabetic nephropathyComparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with DiabetesTreatment of diabetic kidney disease: current and future targets.Proteomic profile in glomeruli of type-2 diabetic KKAy mice using 2-dimensional differential gel electrophoresis.Glycated albumin and the risk of micro- and macrovascular complications in subjects with type 1 diabetesEffects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study.Tripterygium Glycosides Tablet Ameliorates Renal Tubulointerstitial Fibrosis via the Toll-Like Receptor 4/Nuclear Factor Kappa B Signaling Pathway in High-Fat Diet Fed and Streptozotocin-Induced Diabetic RatsEffect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes.Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice.Beneficial effects of previous exercise training on renal changes in streptozotocin-induced diabetic female rats.New therapeutic agents in diabetic nephropathy.MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease.Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease.Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea.Lipoprotein(a) predicts a new onset of chronic kidney disease in people with Type 2 diabetes mellitus.Association between poor psychosocial conditions and diabetic nephropathy in Japanese type 2 diabetes patients: A cross-sectional study.Rutin suppresses high glucose-induced ACTA2 and p38 protein expression in diabetic nephropathyVisualization of kidney fibrosis in diabetic nephropathy by long diffusion tensor imaging MRI with spin-echo sequence.Inhibition of 12/15-Lipoxygenase Reduces Renal Inflammation and Injury in Streptozotocin-Induced Diabetic Mice.Sphingosine kinase 1 mediates AGEs-induced fibronectin upregulation in diabetic nephropathy.Regulatory T cells in Acute and Chronic Kidney Diseases.Urine clusterin/apolipoprotein J is linked to tubular damage and renal outcomes in patients with type 2 diabetes mellitus.Critical Shear Stress is Associated with Diabetic Kidney Disease in Patients with Type 2 Diabetes.Herba Artemisiae Capillaris Extract Prevents the Development of Streptozotocin-Induced Diabetic Nephropathy of Rat.Is decreased lung function associated with chronic kidney disease? A retrospective cohort study in Korea.Previous Exercise Training Reduces Markers of Renal Oxidative Stress and Inflammation in Streptozotocin-Induced Diabetic Female Rats.Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia
P2860
Q26745623-3CB0583B-00A3-49FE-B9DF-99334B0EA736Q33889894-A5976E25-3EE4-4531-A8BF-33E170D0496FQ33907249-E20F77CA-9187-43DA-9158-053878317CB2Q34783098-7CFFEA66-E984-405D-A4F7-093117FE0337Q35627229-437C8595-EC1E-4A95-ABE2-FD41EC82EE60Q35986524-55FFEA26-8420-4EBA-B9AE-262A1D7D1E28Q35996116-AD29A6CB-D7C6-4642-AC82-4D5B9C4C40AAQ36179371-7D2E8846-DCA9-4F9F-9A34-260F2904DC1DQ37056839-6E2A65B5-7B05-48CF-9656-D2FB87A0D1A5Q37071619-AA2F950B-9760-4FA1-8E68-27549A325B98Q37559164-174A90EF-83F0-4669-871E-6787CAA1ABFCQ37565264-CB2C0E13-F34B-4AD7-A4EB-32751A16B119Q37611255-FEDFE2F4-F8F5-4D42-9F26-C8E521C7B163Q38533385-57B38CB9-6C4F-44AC-BB2C-BF6D718D14EDQ38934196-88537CA2-AE8D-4534-A733-E14F9F9E6248Q38981985-C05334DB-71E7-4170-BFDD-B9EFCF55E214Q40344091-348C0262-6015-4EB2-BEC5-1C9988CBC8ACQ41017856-9EEA9816-BE00-4E56-B6FF-2339F88FC50DQ41050644-2AF07539-B3D4-4ED6-9CF4-20906920353AQ42228384-3C7C2D59-326D-4C57-AC6F-B15DBF94455CQ43907810-3112C76E-A755-43BF-91B8-D9393591EEC6Q45066685-FE1AA594-B296-4F4F-AF96-013F090763EEQ48244006-6ACFE7F2-B7A7-48D1-A534-F0E7D7BDD67EQ49589747-D28CE65E-BEBC-4C45-BE31-C5C638E3F339Q52595165-83948AB3-8CFE-4AA7-8528-DC3C4E4A84CCQ53828969-499F5243-6BDF-4C18-A8F8-91FCF4A587E9Q55213982-0CC1BCA4-D762-4CE3-9A79-9DC96F04B4C1Q58699037-A34BA341-96C7-420E-8A30-D32F520DC334
P2860
Diabetic kidney disease: from epidemiology to clinical perspectives.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Diabetic kidney disease: from epidemiology to clinical perspectives.
@ast
Diabetic kidney disease: from epidemiology to clinical perspectives.
@en
Diabetic kidney disease: from epidemiology to clinical perspectives.
@nl
type
label
Diabetic kidney disease: from epidemiology to clinical perspectives.
@ast
Diabetic kidney disease: from epidemiology to clinical perspectives.
@en
Diabetic kidney disease: from epidemiology to clinical perspectives.
@nl
prefLabel
Diabetic kidney disease: from epidemiology to clinical perspectives.
@ast
Diabetic kidney disease: from epidemiology to clinical perspectives.
@en
Diabetic kidney disease: from epidemiology to clinical perspectives.
@nl
P2860
P1476
Diabetic kidney disease: from epidemiology to clinical perspectives.
@en
P2093
Cheol Whee Park
P2860
P304
P356
10.4093/DMJ.2014.38.4.252
P577
2014-08-01T00:00:00Z